A time-in-motion study of oral ibandronate versus iv zoledronic acid for treatment of metastatic bone disease in breast cancer patients No significant financial relationships to disclose. This is an ...
As we look to spring Clinical Competency Committee (CCC) meetings, it’s time to evaluate your own evaluation process. Milestones spring reporting is taking place now through June 25, 2021, and these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results